News & Articles
Selected Filters:
Thermo Fisher Scientific introduces Invitrogen Vivofectamine Delivery Solutions
A nucleic acid delivery solution to advance life science research and genetic medicines
Integrating Cytiva Protein Select tag into an expression vector
Explore guidelines and recommendations for the design and generation of DNA constructs to generate a recombinant protein with the Cytiva Protein Select resin
Scale Biosciences and Revvity’s BioLegend launch high parameter protein profiling of single cells
The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level
Management by walking around (MBWA) in the clinical laboratory
Guest editorial by Susan Dawson, Consultant, Speaker, Writer at Accomplish More Consulting Services (AMCS)
Recombinant protein purification process development
A case study comparing process development for the purification of recombinant proteins using Cytiva Protein Select resin vs a nonaffinity method
Implementing high-sensitivity troponin assays into clinical practice
Expert roundtable forum discussion to explore the value of high-sensitivity immunoassays
BIOFIRE FILMARRAY Tropical Fever Panel receives US FDA Special 510(k) clearance
Tropical Fever Panel a syndromic PCR test, targets the causes of tropical fever infections
Researchers gain early insights into CAR T efficacy with patient-derived glioblastoma organoids on Maestro Z
New frontiers in glioblastoma: Patient-derived organoids on Axion BioSystems’ Maestro Z impedance-based live-cell analysis system offer new insights into CAR T bioactivity and immunotherapy efficacy
AI-powered blood test first to spot earliest sign of breast cancer
A study suggests a new screening method that combines laser analysis with a type of AI is the first of its kind to identify patients in the earliest stage of breast cancer
Patient trial finds biomarker test could significantly reduce antibiotic use in sepsis
The study was commissioned and funded by the National Institute for Health and Care Research (NIHR), and its leading partners were The University of Manchester, Northern Care Alliance NHS Foundation Trust and Warwick Medical School’s Clinical Trials Unit, who specialize in research in emergency and critical care
Empowering laboratory professionals for a healthier tomorrow with ADLM
Find out how CLINICAL24 supporter, ADLM, advances clinical laboratory medicine by empowering laboratory professionals
T2 Biosystems expands its leadership in direct-from-whole-blood detection of sepsis-causing pathogens
T2 Biosystems announces plans to license its proprietary technology to accelerate the broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue stream
24 hours in the life of a scientific assistant in India
Latest Seal of Quality Awards announced
Find out which products have earned a new Seal of Quality, including the rare Diamond Seal of Quality
Abselion raises £6.6M led by M Ventures to bring Amperia to market
Series A financing highlights the potential impact of Abselion’s technology for life science research and bioprocess development
Beckman Coulter Life Sciences launches Cydem VT Automated Clone Screening System
High-throughput platform accelerates drug discovery by reducing the number of manual steps by up to 90%
Nominate your favorite new lab product of 2024 for a Scientists’ Choice Award
Tell us which new products have had the biggest impact on your lab work for a chance to win one of five $100 Amazon.com Gift Cards
LIVE: Today's the day! Join us for our CLINICAL24 event
Study links rare genetic mutation to severe neurological disorder
Research at Karl Landsteiner University of Health Sciences offers new insight in brain connectivity and development
INTEGRA’s pipetting solutions support business diversification
Learn how BioApp Solutions enhances liquid handling efficiency with INTEGRA Biosciences' pipettes
Roche receives FDA approval for PATHWAY HER2 (4B5) test
The PATHWAY HER2 (4B5) test helps identify patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer (BTC) who may be eligible for treatment with ZIIHERA
Abzena expands analytical capabilities to include GMP cell-based potency testing across US & UK sites
The expansion enhances Abzena’s extensive bioassay offering, providing customers with a more comprehensive, streamlined, and cost-effective way to access critical data faster